Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China · Delayed Price · Currency is CNY 98.80
-2.70 (-2.66%)
Apr 17, 2026, 3:00 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 26.15 billion as of April 17, 2026. Its market cap has increased by 6.07% in one year.
Market Cap
26.15B
Enterprise Value
25.25B
Revenue
810.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
98.80
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 26.15B, an increase of 46.09%. That is a compound annual growth rate of 6.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 26.15B | 6.58% |
| Dec 31, 2025 | 24.54B | 48.77% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asymchem Laboratories (Tianjin) | 40.36B |
| Hebei Changshan Biochemical Pharmaceutical | 40.14B |
| Shanghai RAAS Blood Products | 37.37B |
| Chongqing Zhifei Biological Products | 37.03B |
| Beijing Tiantan Biological Products | 30.02B |
| Hualan Biological Engineering | 27.48B |
| Xiamen Amoytop Biotech | 26.37B |
| BrightGene Bio-Medical Technology | 24.23B |